From stratospheric antennas to implantable bio-sensors, from the thermodynamics of carbon capture to quantum technology and AI-designed biology, we use deep tech to challenge and change the status quo.

Read our latest research and insights to help you see beyond the innovation hype and find out how emerging technologies are solving important business problems.

The Medicine Maker, Rob Collison

Champions of Cell and Gene Therapy – The Medicine Maker

How do we ensure that not only the rich benefit from cell and gene therapy? Rob Collison of Cambridge Consultants says: It’s about more than cutting costs ...
Connected healthcare digital biomarkers

Digital biomarkers for patient-empowering connected health

The future promises a digitally connected healthcare system that empowers both patients and carers alike. So, what’s the next step for pharma companies and device developers with ambitions in the space? ...
Technology Networks, Andrew Goulter

In vitro diagnostics needs seismic change to improve patient outcomes and deliver economic benefits – Technology Network

The current state of in vitro diagnostics is no longer fit for purpose. Inadequate procedures mean that critical insights are often missed, while expenditure statistics on both sides of the Atlantic reveal lagging levels of investment ...
The Engine MIT venture ecosystem

CC and The Engine venture ecosystem: an alignment of ambition

We're ramping up our commitment to The Engine, the ambitious venture ecosystem spun out of MIT to support ‘Tough Tech’ companies and solve key challenges in climate change, human health and advanced systems ...
Web3 distributed data architecture

Getting the right distributed data architecture for you

To decentralise, or not to decentralise, that is the question. This Web3 dilemma reflects the likely thoughts of current digital leaders who want to make the best use of their digital assets while maintaining trust in their data systems ...
Contamination detection innovation for cell and gene therapy

Can cell therapy become cheaper and easier?

Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in synthetic biology, Matthew Jones is part of a team addressing this issue in ...
Neuropathy screening from diabetic retinopathy images

Neuropathy screening from diabetic retinopathy images

People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images ...
AI-powered digital pathology

Pathology: time for digital transformation?

In essence, the approach to pathology has remained unchanged for years – but is it time for pathologists to experience digital transformation powered by AI? ...
Sustainable materials database for net zero

Sustainable materials database for project net zero

The ambition to reduce or eliminate single-use plastics from the world’s supply chains is of course as laudable as it is essential. A team at CC is dedicated to doing something about it – by creating a guide to help ...

Deep tech

Are you curious about new technologies, and how they can lead to long-term sustainable value?

We think creatively at the intersection of business and technology, inventing solutions to redefine what you do.

Industries

You need a partner with intimate knowledge of your industry and proven experience of delivering value from deep tech breakthroughs.

Discover more about the work we do in your sector and how we can create real commercial advantage for you.

Insights

Take a look at the latest insights, ideas and perspectives from CC.

Explore a cross-section of up-to-date content on the deep tech trends shaping the future of business and society.

Careers

Are you looking for an opportunity for your abilities to be recognised, and make a real difference?

Whether you are just starting out or you’re an experienced professional, we would love to hear from you.